Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Progenics Pharmaceuticals Inc. PGNX

Healthcare Biotechnology
"Progenics Pharmaceuticals Inc is an oncology company focused on developing and commercializing targeted medicines and artificial intelligence to treat cancer. Its portfolio includes AZEDRA (to treat malignant and recurrent pheochromocytoma and paraganglioma); 1404 and PyL (imaging agents for prostate cancer); 1404 Index and PyL (analytical tools for analysis and indexing of images for prostate... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:PGNX)

Data from Pivotal Phase 2b Study of Progenics’ AZEDRA® (iobenguane I 131) to be Presented at the North American Neuroendocrine Tumor Society 2017 Annual Symposium

GlobeNewswire October 4, 2017

Progenics Pharmaceuticals to Present at the Cantor Fitzgerald 2017 Global Healthcare Conference

GlobeNewswire September 20, 2017

12 Biggest Mid-Day Gainers For Monday

Benzinga.com  September 18, 2017

Biotech Stocks on Investors' Radar -- PDL BioPharma, Progenics Pharma, Agenus, and Aptose Biosciences

PR Newswire September 12, 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenics Pharmaceuticals Inc. - PGNX

PR Newswire September 1, 2017

12 Biggest Mid-Day Losers For Friday

Benzinga.com  September 1, 2017

Mid-Day Market Update: Palo Alto Networks Surges After Strong Q4 Results; Ambarella Shares Plunge

Benzinga.com  September 1, 2017

Progenics Pharmaceuticals Presents Data from AZEDRA® Pivotal Phase 2b Study at the 5th International Symposium on Pheochromocytoma and Paraganglioma

GlobeNewswire August 31, 2017

Progenics Pharmaceuticals Provides Update on Timing of NDA Submission for AZEDRA®

GlobeNewswire August 31, 2017
View More News ››

Opinion & Analysis (NDAQ:PGNX)

Big money to be made in biotech stocks

Andrew Mickey December 1, 2008
View More Opinion ››

Bullboard Posts (NDAQ:PGNX)

Easy $6

Extremely undervalued
Stocktrackers - February 8, 2019

Making a nice move up today on no news.

It is on a fast track course for approval of a new drug.  I wonder if something is not stirring, as the share price has sure got...
Techkim - February 26, 2018

PGNX Announces Details of $0.45 Per Common Share S

PGNX CAPITAL CORP. NEX BOARD : PGN.H   October 12, 2012 09:00 ET PGNX Announces Details of $0.45 Per Common Share Special...
box532 - October 12, 2012

Pharms potential

Pharms are always in need, therefore despite short investments, it would be required even through a mild recession. Also "In the...
amy89 - March 12, 2008

Good Entry Point

I think this stock is going higher and we need to start a discussion!
rtiessen - March 15, 2007
View more Bullboard ››

Indiva Ltd

Indiva Ltd

Indiva Limited, through its indirect wholly owned subsidiary, Indiva Inc., is a Canada-based producer of cannabis servicing ...
View More »